信测标准(300938) - 2024 Q3 - 季度财报

Revenue and Profit - Q3 2024 revenue reached ¥184,105,400.27, an increase of 1.84% year-over-year, while year-to-date revenue totaled ¥551,250,576.88, up 7.95% compared to the same period last year[2] - Net profit attributable to shareholders was ¥50,285,094.87, a decrease of 1.65% year-over-year, with year-to-date net profit at ¥143,071,222.36, reflecting a growth of 7.43%[2] - Revenue for the third quarter reached ¥551,250,576.88, an increase of 7.95% compared to ¥510,667,571.52 in the same period last year[8] - Net profit for the period was CNY 148,251,777.33, reflecting a growth of 2.9% from CNY 144,785,371.18 year-over-year[18] - The total profit for the period was CNY 170,659,596.52, up from CNY 163,669,871.23, reflecting a growth of 5.8%[18] Earnings Per Share - Basic earnings per share for the quarter was ¥0.3356, up 6.10% year-over-year, while diluted earnings per share decreased by 6.71% to ¥0.2947[2] - Earnings per share (EPS) increased to 0.9339, up from 0.8197 in the previous year, indicating a 13.9% rise[18] Assets and Equity - Total assets as of the end of the quarter were ¥1,982,330,147.32, down 7.60% from the previous year-end, and total equity attributable to shareholders was ¥1,157,261,077.42, a decrease of 11.73%[2] - The company's total assets amounted to CNY 1,982,330,147.32, down from CNY 2,145,286,847.04 in the previous year, representing a decrease of 7.6%[16] - The company's equity increased to CNY 1,236,390,926.76 from CNY 1,387,298,583.51, showing a decline of approximately 10.9%[15] - The company's total equity attributable to shareholders decreased to CNY 1,157,261,077.42 from CNY 1,310,992,841.04, a decline of 11.6%[16] Cash Flow - Cash flow from operating activities for the year-to-date period was ¥141,470,007.68, an increase of 4.60% compared to the same period last year[2] - Net cash flow from operating activities improved to ¥141,470,007.68, up 4.60% from ¥135,247,078.77 in the prior year[8] - The net cash flow from investing activities was ¥76,768,693.54, a substantial increase of 185.48% compared to -¥89,806,958.06 in the same period last year[8] - Cash received from operating activities was CNY 484,385,150.41, up from CNY 475,855,277.86 in the previous period[20] - Cash outflow from financing activities totaled CNY 332,707,497.27, compared to CNY 67,297,617.64 in the previous period, indicating increased financing activities[21] Liabilities and Borrowings - The total liabilities of the company as of September 30, 2024, were CNY 745,939,220.56, compared to CNY 757,988,263.53 at the beginning of the period, indicating a slight decrease[15] - The company’s short-term borrowings remained stable at CNY 3,000,000.00[15] Investments and Expenses - Investment income surged to ¥6,043,289.33, a remarkable increase of 2434.80% from ¥238,413.19 year-on-year[8] - Financial expenses rose significantly to ¥2,182,439.84, marking a 161.54% increase from a negative amount of -¥3,546,522.42 in the previous year[8] - Research and development expenses rose to CNY 45,526,717.68, compared to CNY 39,936,521.06 in the prior year, marking a 13.5% increase[17] - Total operating costs were CNY 387,750,065.10, which is an increase of 8.4% from CNY 357,665,336.42 year-over-year[17] Share Repurchase and Shareholders - The company repurchased shares amounting to ¥199,999,963.49, which significantly impacted the cash flow from financing activities, resulting in a net outflow of -¥332,701,994.84[12] - The company has completed its share repurchase plan, having bought back 7,552,015 shares[12] - The number of ordinary shareholders at the end of the reporting period was 8,992[9] Other Financial Metrics - The weighted average return on equity was 4.38%, reflecting a slight increase of 0.20% compared to the previous year[2] - The company reported a financial expense of CNY 2,182,439.84, compared to a financial income of CNY 3,546,522.42 in the previous year, showing a significant shift in financial performance[17] - The company reported a decrease in revenue from its subsidiary, with a decline of approximately 28% in testing equipment sales[8] Cash and Cash Equivalents - The company’s cash and cash equivalents decreased by 32.45% to ¥238,103,646.44, largely due to stock repurchases during the period[7] - The net increase in cash and cash equivalents was -¥114,611,682.66, reflecting a 426.44% decrease compared to -¥21,771,083.07 in the previous year[8] - The ending balance of cash and cash equivalents was CNY 237,844,218.35, down from CNY 406,568,683.03 in the previous period[21] Recognition and Market Position - The company was recognized as a national-level specialized and innovative "little giant" enterprise, enhancing its market position and growth potential[14] Audit Status - The company did not conduct an audit for the third quarter report[22]